In studies of cancer in man the time of onset of symptoms is commonly taken as the origin on the time scale. Clinicians in particular refer to this when they attempt to assess the consequences of delay in the diagnosis and treatment of cancer. This concept of delay is a central theme of cancer control programmes in countries all over the world, and reduction of the delay ranks high among the objectives of all such programmes. With this in view great emphasis has been placed on education of the public, the cancer patients of the future, since it has been found that a major part of the delay is in fact ascribable to the patient. But nowhere have educational campaigns been strikingly successfulno more so than educational campaigns levelled at the habit of cigarette smoking.
However, in recent years the problem of delay is increasingly being attacked in a different way. Instead of passively waiting for the patient to notice symptoms and then to decide when it is time to consult a doctor, the medical profession has in many areas started an active search for cancer cases by screening large numbers of persons the great majority of whom have no symptoms at all at the time of the examination. As a result premalignant and very early malignant lesions are being detected in increasing numbers, and evidence of the significance of finding and treating such lesions is beginning to accumulate.
Unfortunately, in the majority ofmass screening programmes the beneficial effect has been taken for granted and the need for measuring the effect has been ignored. Those few programmes that have provisions for evaluation of results properly built into their design are relatively recent and have not yet reached the stage when they can show us definitely the value and limitations of mass screening for cancer.
Despite these shortcomings the following discussion of the presymptomatic diagnosis of cancer will be based entirely on the results of mass examinations. There is no other source of information. But although mass examinations are aiming at earlier diagnosis they are not usually evaluated according to whether or not the cases detected were free of symptoms. To a large extent we shall have to draw inferences based on other indices of the earliness of diagnosis.
EVALUATION OF MASS EXAMINATIONS
The Study Population Ideally evaluation should be based on a defined population which has been randomly divided into two groups, one of them to be subjected to periodic mass examination while the other would serve as the control group. Projects with such a design do exist but are rare. Usually mass examination is offered to a population group and some members choose to participate while others do not. Observations made on those attending are subsequently compared with data pertaining to those not attending, or with other available data, such as figures for the nation as a whole. In doing this it is too often forgotten that such comparisons may be fallacious, primarily due to the self-selection which has taken place.
To some extent the nature and consequences of this selection are well understood. Several studies carried out in connexion with screening of the population for cervical cancer have consistently shown that although married women are more inclined to attend than the single, the lowest participation is from those women who have the highest morbidity and mortality from cervical cancer. Conversely, the women with the highest attendance rates are those who are least likely to benefit from the examination, not only because the incidence of the disease is low among them but also because they are the ones who are most likely to see the doctor early if symptoms develop (Breslow & Hochstim 1964 , Jones & Brown 1965 .
One observation commonly made in mass examinations is that the attendance rate tends to drop markedly when examinations are repeated, e.g. from 80 % on the first screening to 50 % or less on a second screening. This is particularly disturbing if the drop is accompanied by an accentuated negative selection for examination. One consequence of such a trend, from the point of view of evaluation, is that it becomes difficult to compare the results of successive examinations. For example, if a first screening with a high attendance rate and a high yield is followed by a second screening with a low attendance rate and a low yield, it may not be justified to attribute the difference in yield exclusively to the 'preventive' effect of the first screening.
Negative selection for examination may be expected in several types of mass examinations for cancer. For example, the heavy cigarette smoker would hardly be very receptive to the idea of periodic screening for lung cancer.
Characteristics ofthe Cases Detected
Another selection mechanism, more difficult to assess, affects the characteristics of the cases that are detected by mass examination (Dunn 1955) . The stage distribution of these cases obviously depends on the stage distribution of the cases existing in the population at the time of the screening, on whether or not attendance is associated with stage, and on the ability of the test procedure to give a positive result at various stages of development of the disease. However, it is well known from cancer and from other fields of human pathology that the relatively benign, slowly progressing cases accumulate disproportionately among prevalent cases as compared to incident cases. Consequently a mass examination tends to find disproportionately many cases that give the impression of being 'early' simply because they are relatively slow-growing. This selection will be reflected in the stage distribution of the cases, in the proportion that can be given radical treatment and in the survival experience of the group. This bias should be less disturbing in material obtained by rescreening of the same population at suitable intervals but may be of importance even under such conditions. While the more malignant tumour compels the patient to seek medical attention irrespective of when there is going to be a mass examination, the more benign variety permits the patient to wait for the next periodic examination.
Problems ofClassification
Cytological screening programmes for the detection of cancer of the cervix and, more recently, the search for breast cancer in asymptomatic women by means of soft tissue mammography have given rise to special problems of diagnosis and classification. Pathologists are with increasing frequency requested to examine tissue specimens for lesions that cannot be seen by the naked gye nor felt by palpation. In turn, clinicians have to adapt to new histopathological concepts such as dysplasiasubdivided according to gradecarcinoma-in-situ, carcinoma-in-situ with micro-invasion, and occult invasive carcinoma. Knowledge concerning the reproducibility of these diagnoses is still very imperfect. Moreover, while there is strong evidence that these conditions do represent sequential phases of onc disease process (Koss et al. 1963 , Bryans, Boyes, Boyd & Fidler 1964 , progression is not obligatory, and the probability of progression, persistence, and regression of untreated lesions is far from well established. It is important to realize that their biological significance cannot be learnt from studies confined to cases thus classified. It is necessary to study also the populations from which these conditions are being eliminated by treatment of the cases. The well-designed mass examination, therefore, has an essential part to play in the study of the nature of these conditions.
Assessment ofSurvival
Because material from a mass examination is likely to contain disproportionately many relatively benign cases a conventional study of survival in such a group may convey a too optimistic impression of the value of the project. It is even more disturbing, however, that as the time of treatment is being steadily pushed back, as in cancer of the cervix due to cytological screening, the length of survival after treatment is bound to increase, but it is impossible to tell how much of this increase represents real gain in length of life and how much is due to the moving back of the point from which time is measured (Dunn 1965 ).
Stutdy ofDeath Rates
Problems such as those mentioned lead to the conclusion that the final evaluation of mass examinations must be based on observations of the trends in death rates among whole groups of the population to whom the programme is applied.
As an intermediate step one may attempt to demonstrate a reduction in the incidence of invasive cases in programmes, such as the cytological screening for cancer of the cervix, which lead to detection and elimination of a large number of pre-invasive lesions. But ultimately a decline in death rates should result. An evaluation of mass examination programmes in terms of their effect on incidence and death rates in the population is being attempted in several studies today. We shall consider the results of some of them.
CANCER OF THE CERVIX
Attention will be confined to programmes using the cytological examination as a first-line screening method. Technical aspects of this method (irrigation smear versus cervical scraping, &c.) and methods of clinical follow up of positives and suspects will not be discussed.
The cytological technique and its increasing use in mass screenings for cancer of the cervix is considered by many the most remarkable advance in cancer control in our time, offering hope of a drastic reduction of cervical cancer mortality in the populationsome even foresee eradication of this disease. The cytological examination gives a positive result in the very earliest phases of invasive cancer of the cervix thus enabling treatment to be started when it is most likely to be successful. Still more important, the examination also gives a positive result for pre-invasive lesions, and by adequate treatment of these progression to invasiveness can almost with certainty be prevented. The measurable results of large-scale application of this test to a population should consequently be a marked reduction in the incidence of invasive cancer of the cervix, followed by a marked decline in the death rate. The question is whether this expectation has yet been fulfilled.
One of the studies most frequently referred to in recent years is the cytological screening programme that has been going on in British Columbia since 1949. The results reported from this study are by many regarded as the most convincing demonstration of the effect of mass screening. The programme developed gradually and by 1962 the number of women screened each year exceeded 100,000 which corresponds to approximately 1 out of 5 of all women over the age of 20 years in the background population.
By the end of that year 55 % of all women over the age of 20 years had been screened at least once.
Since 1955, the first year for which reliable data were available, a drop has been noticed in the recorded incidence rate of invasive cancer of the cervix in the total population, and there was a 45 % decline between 1955 and 1962 . This decline has been ascribed to the screening programme, presumably being due to the detection and elimination of a large number of carcinoma-in-situ and other preclinical/premalignant lesions, and a smaller number of invasive lesions, among those screened.
The validity of this explanation should become clear when a few more years of observation are added. At present the data can be regarded as suggestive only. Experience from other areas indicates that in an expanding programme the recorded incidence of invasive cancer will initially not decline but increase, due to the detection of prevalent invasive cancer (Kaiser et al. 1960 , Lundin et al. 1965 ). Furthermore, the decline in incidence rates in British Columbia has been going on since 1955 although at that time the screening was on a relatively small scale, reaching only 10,000 women. By 1955 the number of carcinoma-in-situ lesions detected each year was approximately 50. Between 1960 and 1962 the figure rose from 200 to 300, the latter figure being approximately three times the annual number of newly diagnosed invasive cases in the total background population. If the decline in recorded incidence of invasive cancer observed in the early years after 1955 were essentially due to the screening off of approximately 50 in-situ lesions per year, then the detection of a much higher number of such lesions after 1960 should have been accompanied by a steep acceleration of the rate of decline. This has not yet been the case.
One may speculate whether the recorded decline in invasive cancer may to some extent have been due to changes in the population studied. Between 1955 and 1962 this population increased from 423,000 to 503,000 -or by nearly 20% -a figure that might reflect a substantial immigration, especially as it is stated that the age distribution has remained essentially unchanged throughout the period.
Perhaps the strongest indication of a favourable effect of the screening programme is provided by the extremely low incidence of invasive cervical cancer now observed among those previously screened. In 1961-2 the annual incidence per 100,000 was 3*5 -a rate that cannot easily be ascribed to over-representation of low risks among those participating in the programme.
Up to 1964 there has been no sign of a reduction in the mortality rate of cancer of the cervix in British Columbia, an observation which, should it persist, would be extremely difficult to reconcile with the recorded decline in invasive cancer over the last ten years.
A somewhat different picture emerges from New York State,' (New York State Department of Health 1964). This State has had a cytology programme for many years, rapidly expanding after 1955. In 1964 the number of smears examined during the year exceeded 500,000a figure corresponding to 1 out of 6 of all women in the State over the age of 21 -years.
In this State the mortality rate of cancer of the cervix has been decreasing at a steady rate since 1947, that is since before the start of the screening programme. The incidence rate of invasive cancer of the cervix also has decreased during the same period, closely paralleling the mortality rate. As far as the two curves are concerned there is no indication that the forces which determine their slope have changed materially during the period. A third example is a current study in Norway. In this country, as in many others, the ageadjusted death rate from cancer of the cervix has been slowly declining for some time (Fig 1) . The curve shown is very similar to those for New York State, Memphis and Shelby County (Tennessee), and some other areas in the United States where the downward trend has been ascribed to screening programmes. Before 1960 very limited use was made of cytological examination in Norway. However, at that time population screening was started in one county (Ostfold) for the sole purpose of assessing the effect of such a programme. The plan was to examine as many as possible of the 46,500 resident women aged 25 to 59, to repeat the screening after two years and again after another three years. The field work was to be carried out by a team of women doctors who would undertake a pelvic examination in addition to obtaining material for the smears. This study was organized by the Norwegian Cancer Society in close co-operation with the Health Services of Norway.
Attendance at the first screening was 77 %-80 % among the ever married and 50% among the never married. The second screening, now practically completed (1966), has had a somewhat lower attendance rate, yet no less than 74% of those who participated the first time also did so the second time. Some of the findings are shown in Table 1 (actual numbers) and Table 2 (rates per 1,000 examined). The rates, and their trend, are closely similar to those observed in many other studies. The rates shown are crude as the age distribution of the two categories of respondents on the second screening is not yet known. It is unlikely, however, that age-adjustment will materially change the impression conveyed by Table 2 . Among the cases of dysplasia, in-situ lesions, and invasive cancer of the cervix detected at the first screening, approximately 50% admitted having symptoms at the time of the screening, the percentage being essentially the same for each of these three categories of patients. Discharge was the predominant complaint. Among all women screened, 35% stated they had symptoms from the genital organs. Table 3 indicates that in 1965 there was still no sign of a decline in the number (or in the incidence rate) of invasive cervical cancer in the total population although by that time a large fraction of the female population had been screened twice. The most striking observation is that the number of cases diagnosed in stages II and III seems to have been unaffected by the programme. An explanation for this is suggested by the preliminary data in Table 4 , showing all invasive cervical cancers diagnosed in 1964 and 1965 among resident women eligible for screening (women born 1900 and later), by stage at diagnosis, according to whether or not the cases were detected by the screening programme, and according to whether or not they had previously been screened.
The first screening in 0stfold was completed in 1963. The second and tird screenings had ""N\ started in 1961 and 1964 respectively, and these two phases of the programme proceeded simultaneously in 1964 and 1965 but in different parts of the county. By the end of 1965 the second screening was almost completed. The third screening was nearing completion in the urban areas of the county but had not yet started in the rural areas. The most striking observation in Table 4 is that the majority of the advanced cases diagnosed in the county stem from that very small proportion of the population who had never attended the screening programme. In fact, the annual number of stage II and III cases produced by this group of women nearly equals the annual number of advanced cases produced by the total resident population of corresponding age groups before the screening programme started. Thus, although the figures from 0stfold are still rather small they are consistent with other data showing that those women who fail to attend cytological screening programmes are indeed a highly selected highrisk group. As long as the programmes fail to attract these women, the reduction in incidence and especially in mortality of cervical cancer in the population is bound to be modest. Table 4 also shows that no fewer than 22 of the 44 cases of invasive cancer diagnosed in 1964-5 were in women who had undergone screening at Table 4 Cervical cancer in 0stfold, Norway. New invasive cases diagnosed in 1964 and 1965 among resident women eligible for screening (women born in the year 1900 and later), by stage at diagnosis, according to whether the cases were detected by the screening programme, and according to whether they had pTeviously been screened least once before. Fourteen of these were detected by the current, second or third, screening; from two to three years had elapsed since they were last tested, with negative results, and all but one were in stage I when detected.
For the remaining 8 cases (conventional consultation, previously screened) the interval since the previous screening was shorter. The time for their next test had not yet come when they developed symptoms that induced them to consult a doctor. Although the figures for the two years are small they seem to suggest that the stage distribution for these cases is less favourable than for those 14 who were detected by rescreening according to the prearranged timetable. In other words, it seems as if the former cases are the more highly malignant ones as they have apparently progressed to a more advanced stage in a shorter timetime being measured from the previous negative test. That the previous smears were in fact negative has been confirmed by re-examination of the slides.
Clearly, the present data do not yet justify firm and final conclusions, but we are inclined to regard the observations just described as reflecting a tendency for periodic mass screenings to favour the detection of the relatively benign varieties of tumours. Data now accumulating in 0stfold and elsewhere will soon make it clear whether and to what extent this impression may be correct. Should the observations be corroborated, then there would be some justification for the claim that today's periodic mass screenings for cancer of the cervix 'attract the wrong persons and detect the wrong cases', and it would be easier to understand why these very comprehensive, programmes apparently do not have quite the impact on population rates which has been predicted for them.
By 1965 there was still no evidence that the mortality of cervical cancer is declining any faster in 0stfold county than in the country as a whole. However, the period of observation is still rather short.
BREAST CANCER
With few exceptions the first observation leading to the diagnosis of breast cancer is made by the patient. Having noticed symptoms she will consult a doctor after a period of self-observation that may be very much longer than the patient will readily admit. Cancer control programmes have for years emphasized the importance of early diagnosis in breast cancer, and great efforts have been made to reduce the delay ascribable to the patient by means of educational campaigns. The aim of these has been partly to make the women aware of certain 'danger signs' which should prompt them to seek medical attention, and partly to teach them the technique of self-examination. The routine annual breast examination by a doctor, using the classical inspection and palpation, has had many advocates, particularly in the United States. Although great efforts have been put into these kinds of programmes, there has apparently nowhere been any adequate attempt to measure their effects. But studies carried out in Norway have produced some relevant information.
During the early 1950s periodic mass examinations for breast cancer became very popular among Norwegian women. The examinations were usually arranged by local divisions of voluntary health organizations which persuaded the local physician to undertake a breast examination of the women in the area once a year. Some of the physicians who participated in this activity were enthusiastic and claimed, without evidence, that the examinations resulted in the early detection of a substantial number of breast cancer cases. The majority of the medical profession, however, including the Medical Association, held that the examinations were at best a waste of time and that they could be positively harmful by creating cancer phobia on the one hand, and a false sense of security on the other. By the middle of the 1950s periodic mass examinations for breast cancer were well established. They were receiving financial support from county authorities in some areas, and requests for support were beginning to appear with increasing frequency in government offices. Considering the situation at this stage the Norwegian Cancer Society found that very little was known regarding the value of such examinations and they decided that this question was sufficiently important to justify a large-scale experiment. To plan and carry this out a special committee was appointed by the Cancer Society. The decision was not as drastic as it might seem. The activity was there. It had to be organized to make sure that at least some useful information could be gained from it.
A relatively large and well-defined population was needed for the study. The data which will be presented refer to three counties with altogether 105,000 women in age groups 20-69 yeats.
Local physicians, mostly general practitioners, agreed to do the examinations. It was actually their performance we wanted to test. They were carefully briefed on the objectives of the study, on the techniques of the examination (inspection and palpation), on what questions to ask, and on how to record answers and findings. In particular, they were instructed to make free use of specialists whenever they came across cases that were considered doubtful or suspect.
While the primary objective was to evaluate periodic examinations for breast cancer, it was realized that the survey presented unique opportunities for asking questions of the women. It was decided to utilize the survey to establish material for a prospective study of some of the factors supposed to be related to the etiology of cancer of the breast and genital organs in women.
It was planned to re-examine the women at least once, after two years. Repetition was particularly desirable from the point of view of evaluation but would also enable us to increase the proportion of the population covered, check on missing information and, perhaps, ask new questions. Actually the survey was carried out three times in one of the counties, twice in one county, and only once in the third county. When the field work was ended in 1960 approximately 80% of all married women and 65% of all unmarried women had been examined and interviewed at least once. Characteristically, attendance was better in rural than in urban areas and, in general, was better the longer the distance to the nearest town. In the first survey attendance was 60% in all urban areas and 70% in all rural areas. A total of 72,279 women were examined.
Results
One common way of measuring the effect of a mass examination is in terms of detected cases. However, the definition of 'a case detected by mass examination' is controversial. In our experience, in anticipation of the mass examination many women started self-examination. Some of them discovered a lump, consulted a doctor, and had cancer diagnosed before the survey started. Others discovered a lump or noticed other symptoms before the survey but postponed seeing a doctor since there was to be a mass examination soon.
For such reasons we have preferred the more neutral presentation illustrated by Fig 2 which shows the number of new cases in the total background population diagnosed per month after the first survey had started, compared with the expected number. The latter is the monthly average for the total population in those areas and in the same age groups, based on three years before and three years after the start of the survey. During the first four months, when the first survey was virtually completed, there was a striking increase in the number of diagnosed cases, an excess of 28 cases over and above the expected number. This peak was followed by a depression Expected number is the monthly average for the total population 20-69 years of age in the same areas, based on three years before and three years after the start ofthe programme which corresponds approximately to one-half of the preceding excess. While 51 new cases were diagnosed during the first four months after the start of the survey, only 16 cases were diagnosed during the subsequent six months. The episode is unique. During the following years the number of cases diagnos2d has never shown such large deviations from the expected values. One of the repeat surveys which were carried out in two counties in alternating years did produce fluctuations similar to those in Fig 2 but much less pronounced.
It seems natural to assume that had there been no detection campaign, then approximately half of the excess cases would have been recognized during the following few months while the other half would have been distributed over a longer timeif they had been recognized at all. Other explanations are possible. It could be, for example, that the depression in the curve was due not to a depletion of cases in the population but to a false sense of security created among those who had attended examination, or among the physicians. If that were so, then the antedating of the diagnosis during the survey would presumably be somewhat larger, but this would be more or less offset by increased delay after the survey. Available data on the duration of symptoms before diagnosis lends no support to this hypothesis.
Accepting that antedating of the diagnosis has in fact been achieved for a number of cases, has this had any demonstrable effect on stage distribution? Table 5 shows the stage distribution of all cases diagnosed in the resident population 20-69 years of age before, during, and after the mass examination period which lasted from the middle of 1956 through 1959. When the sum of all cases diagnosed in each of the three calendar year periods is considered, the stage distribution has remained essentially constant. However, when a distinction is made according to whether (1) cancer was detected by mass examination, (2) cancer was diagnosed independently of mass examination, but in women who had at some time attended mass examination, and (3) cancer was diagnosed in women who had never attended mass examination, then some striking contrasts emerge. Clearly, the stage distribution is very favourable among those 60 cases which we consider it justified to classify as having been detected by the surveys. However, it is almost as favourable among those who had attended mass examination and then subsequently had cancer diagnosed in conventional consultation after symptoms had developed ('Consultation, previously screened' and 'After survey, previously screened'). The apparent increase in the proportion of advanced cases in this group in the last period (1960-4) is disturbing. Table 5 Breast cancer detection in Norway. Stage distribution of cases detected, as compared with those diagnosed in conventional consultation before, during, and after the mass examination In contrast, cases diagnosed among those who never attended mass examination show a definitely more unfavourable stage distribution, both during the period when the survey took place and in the following years. Apparently these women are either slower in noticing symptoms of disease and/or less inclined to seek medical attention even after symptoms have been noticed. The analogy with the situation in screening for cancer of the cervix is striking.
As a result of the first survey 950 women were referred to a specialist, that is 1-3 % of all examined. The examining physicians were strongly encouraged to raise their 'index of suspicion' on this occasion. Among those referred, 143 ignored the advice of the physicianand in none of these has cancer been demonstrated so far (1966).
Among the 807 who complied, 300 (37 Y.) had a biopsy and 40 cases of cancer were discovereda yield of approximately 1 in every 1,700 examined. It is noted that the lower age limit for this survey was set at twenty years. Table 6 Breast cancer detection in Norway. Women referred to specialist during the first screening (1956-7), cross-classified Malignancy 17  94  20  131  suspected  Presumably 23  673  123  819  benign  condition  Total  40  767  143  950   Table 6 shows the relation between the provisional diagnosis recorded by the first-line physician and the final diagnosis established by the specialist. Among 131 cases classified by the physician as suspect, 17 turned out to have cancer, while among 819 provisionally classified as benign (actually specified as adenofibrosis, benign tumour, cyst, &c.) 23 were shown to have cancer. In other words, had the examining physicians relied on their own interpretation of their findings, more than half the cancer cases might have been missed at the time.
During the repeat surveys another 20 cases of breast cancer were found. Among the 60 cases detected, 37 (62 %) stated at the time of the survey that they had noticed symptoms for varying periodsa lump, discharge from the nipple or pain. They should have seen the doctor already. The stage distribution for those who denied having noticed symptoms (15 stage I, 8 stage II) was, as would be expected, more favourable than for those with symptoms (15 stage I, 17 stage II, No findings/symptoms 326 2 stage III, and 3 stage IV). Staging has here been based on all available information including the results of histopathological examination. By the end of 1965 the survival experience for patients in a corresponding stage was closely similar for these two groups of patients. It is obvious that some of the cancer cases diagnosed in the years following mass examination had actually been overlooked at the time of the survey. Table 7 suggests that the number of missed cases may have been quite substantial. Among 405 who had attended the mass examination, and in whom cancer was diagnosed during the following years, through 1964, no fewer than 79 (19-5 %) had either subjective symptoms or objective findings at the time of the mass survey, and in most of these, findings or symptoms referred to the breast in which cancer was subsequently demonstrated. None of these had a biopsy in connexion with the mass examination, but 6 had been considered suspect and therefore had been referred to a specialist. There is no way of knowing whether all or some of these 79 actually had cancer at the time of the mass examinationexcept in 4 in whom the diagnosis was established within two months after they had attended mass examination. Although the 79 womehi with symptoms or signs at mass examination had their cancer diagnosed on average more than two years later, their stage distribution was comparable to the most favourable series shown in Table 5 .
This mass examination programme has provided useful material for studies of the epidemiology of cancer of the breast and genital organs.
But there is no indication that it will have any influence on the death rate from breast cancer in the population. Although this is precisely what the majority of experts would predict on the grounds that the detection method is inefficient, it is always worth knowing.
Mammography
The improved technique for radiological examination of the breast which has been developed after 1950 has greatly increased the possibility of achieving earlier diagnosis of breast cancer. This development has taken place at a time when the principles of evaluation of diagnostic methods have become generally appreciated. Few procedures have in such a short time been subjected to so many adequate trials as has mammography. These studies have made it clear that it is possible with this technique to demonstrate palpable lesions radiologically, to predict the nature of the lesions with great accuracy and also to delineate lesions that are truly asymptomatic and not palpable. Perhaps the most striking evidence has come from studies utilizing mammography in the follow up of patients who have undergone unilateral mastectomy for cancer of the breasta group known to have an increased risk of developing cancer of the remaining breast. For example, among 397 patients followed through 1961 and 1962 at the Mayo Clinic, 25 cases of pathologically confirmed cancer of the remaining breast were found (Missakian et al. 1965) . Physical examination alone detected 15 of the 25 tumours, 9 clinically considered malignant and 6 clinically considered benign. Mammography demonstrated carcinoma in 10 cases in which it was not clinically suspected, and suggested the malignant character of the 6 clinically benign tumours. The 10 cases would not have come to operation had it not been for the radiological identification of the lesions.
That the technique developed by Egan (1964) can be learned by radiologists generally, that films of acceptable quality can be produced after a short training course, and that the interpretations provide information which is useful in the clinical management of breast disease, was well demonstrated by Clark et al. (1965) . This study of the reproducibility of the technique was based on 1,580 women who were to undergo biopsy of the breast. It was found that radiologists were able, without benefit of clinical findings, to diagnose correctly 376 of 475 malignant lesions, giving a true positive rate of 79%. Of the 1,105 breasts classified pathologically as nonmalignant, the radiologists correctly diagnosed 999, or 90%. The false positive rate thus was 10 %.
This study also showed that with increasing age of the patient there was an increase in the proportion of malignant lesions that were correctly diagnosed.
Already the use of mammography for screening has been or is being explored by several groups of investigators (Gershon-Cohen & Boreadis Borden 1964 , Shapiro et al. 1966 , Stevens & Weigen 1966 , Wolfe 1965 . Notable among these studies is the one carried out jointly by the Health Insurance Plan of Greater New York and US National Cancer Institute (Shapiro et al. 1966 ). The primary objective of this study is to establish whether a breast cancer screening programme using mammography and clinical examination holds substantial promise for lowering mortality from breast cancer in the general population. Another objective is to determine the frequency with which breast cancer is detected through mammograpny alone, clinical examination alone, and through both methods. The stage of disease when diagnosed by each procedure is recorded, the mortality experience in each category will be established, and it should ultimately be possible to assess the contribution that mammography may be making towards lowering mortality from this disease. Started in 1963, this study is based on representative samples of women aged 40-64 years enrolled in the Health Insurance Plan. They are randomly assigned to study and control groups, each of which is planned to contain approximately 30,000 women, matched by age and other variables.
Briefly, preliminary results show that 23 confirmed cases of breast cancer have been detected in the study group. In 12 of these the biopsy was recommended on radiological evidence alone, in 9 on clinical evidence alone, and in 2 cases on both methods of examination. Involvement of axillary nodes was found in only 1 of the 12 who had biopsy on radiological evidence alone, in 2 of the 9 who had biopsy on clinical evidence alone. In contrast, 14 cases of breast cancer were diagnosed in the same period among women in the control group. Five of these had axillary node involvement.
These preliminary results are highly encouraging and seem to justify intense efforts to modify the technique so that it will be more suitable for large-scale application. At present the time required for an adequate examination and shortage of experienced personnel severely restrict the use of this valuable diagnostic method. It is generally believed that improvement in survival will follow if malignant tumours can be identified at an earlier point in their development. This concept has not gone unchallenged. The stability of breast cancer mortality, in spite of our efforts to change it, is often cited as a case in point. It is still quite possible, however, that success from our efforts is not entirely convincing bvcause we have failed to apply systematically some of the case-finding methods we have for earlier diagnosis, or that the better methods being developed will accomplish this more definitely.
The Composition ofPresymptomatic Disease Before considering specific examples of casefinding methods in identifying presymptomatic cancer it may be worth while to examine the effect of such methods on disease identification in a population. In Fig 1 the development of these to the population that produced them we can calculate the incidence rate. This is the production rate of the disease by the population.
If now we apply a case-finding method capable of identifying presymptomatic disease to this same population we will identify all cases of disease that are at any point in their development before C back to point Bthe minimum limit of the method in identifying disease. The number of cases found in this first application of the casefinding method, which are distributed over the whole segment between B and C, related to the population examined provide prevalence rates for presymptomatic disease identifiable by the particular method. (All reference to prevalence of disease hereafter will be understood to be related to presymptomatic disease.)
If we continue to apply the case-finding method to the population regularly at some appropriate interval all new disease will now be identified at or near point B and we can determine the incidence rate of the disease at point B. If we compared the incidence rate at point B with that previously determined at point C, using the unweighted average of the age specific rates to avoid the biasing effect of general mortality during the time interval B to C, we would expect to find them to be nearly the same. (Actually B will exceed C to the extent that there is a residuum of prevalent disease somewhere between B-C in development at the end of the life span.) This equality also assumes that other causes of mortality do not differentiate appreciably between persons with and without the presymptomatic disease.
The prevalent presymptomatic disease found between points B and C on first examination with the case-finding method is made up of a succession of disease cohorts that have passed point B and are moving towards point C. The incidence rate tells us the population's production rate for the disease per unit of calendar time, and the prevalence rate tells us how many cases of the disease are present-in the population at all times between points B and C in their development. It follows that the ratio of prevalence to incidence provides a measure of the interval B to C in the units of time used for expressing incidence (Dunn 1962 ).
The Meaning ofthe B-C Interval in Case-finding Methods Measurement of the B-C interval provides a means of assessing the ability of the case-finding method to anticipate clinical diagnosis. If the method is insensitive the B-C interval will be
